C. Bart Rountree
Department of Pediatrics and Pharmacology
Pennsylvania State College of Medicine
C. Bart Rountree has not added Biography.
If you are C. Bart Rountree and would like to personalize this page please email our Author Liaison for assistance.
Bone marrow fails to differentiate into liver epithelium during murine development and regeneration.
Hepatology (Baltimore, Md.) May, 2007 | Pubmed ID: 17464997
A CD133-expressing murine liver oval cell population with bilineage potential.
Stem cells (Dayton, Ohio) Oct, 2007 | Pubmed ID: 17585168
Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.
Hepatology (Baltimore, Md.) Oct, 2007 | Pubmed ID: 17668871
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.
Hepatology (Baltimore, Md.) Apr, 2008 | Pubmed ID: 18167064
Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
Stem cells (Dayton, Ohio) Feb, 2009 | Pubmed ID: 19008348
CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.
Hepatology (Baltimore, Md.) Apr, 2009 | Pubmed ID: 19115422
Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.
Hepatology (Baltimore, Md.) May, 2010 | Pubmed ID: 20196115
Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
Hepatology (Baltimore, Md.) Sep, 2010 | Pubmed ID: 20564331
Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.
Gastroenterology Dec, 2010 | Pubmed ID: 20837017
Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization.
Proteome science , 2010 | Pubmed ID: 21092202
Stem cells in drug discovery, regenerative medicine and cancer.
Genome medicine , 2011 | Pubmed ID: 21418554
c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) Sep, 2011 | Pubmed ID: 21618573
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.
Hepatology (Baltimore, Md.) Jan, 2012 | Pubmed ID: 21898502
Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
BMC cancer , 2011 | Pubmed ID: 21929801
Stem cells in liver diseases and cancer: recent advances on the path to new therapies.
Hepatology (Baltimore, Md.) Jan, 2012 | Pubmed ID: 22030746
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。